Plante Moran Financial Advisors’s Royalty Pharma RPRX Stock Holding History

Plante Moran Financial Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$224	Buy	4 +3	+300%	+$156	﹤0.01%	1424
2026 Q1	$61	Hold	1	–	–	﹤0.01%	709
2025 Q4	$49	Hold	1	–	–	﹤0.01%	801
2025 Q3	$45	Buy	+1	New	+$36	﹤0.01%	779
2022 Q1	–	Sell	-581	Closed	-$23K	–	975
2021 Q4	$23K	Buy	+581	New	+$22.6K	﹤0.01%	527

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Plante Moran Financial Advisors's RPRX Position: Q2 2026 in Review

Plante Moran Financial Advisors increased its Royalty Pharma (RPRX) stake by 300% in Q2 2026, buying an estimated $156 and bringing the position to 4 shares worth $224. The position accounts for ﹤0.01% of the portfolio, ranked #1424.

Plante Moran Financial Advisors first reported a position in RPRX in Q4 2021 and has held it in 5 quarters since. The position peaked at $23K in Q4 2021. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Plante Moran Financial Advisors held 4 shares of Royalty Pharma worth $224 as of Q2 2026.
Plante Moran Financial Advisors bought 3 Royalty Pharma shares in Q2 2026, an estimated $156.
Royalty Pharma made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1424 holding.
Plante Moran Financial Advisors first reported a position in Royalty Pharma in Q4 2021 and has held it in 5 quarters since.
Plante Moran Financial Advisors's Royalty Pharma position peaked at $23K in Q4 2021.
647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.